Viva Pharmaceutical recently returned from the Arab Health Expo 2025 in Dubai, one of the world’s largest healthcare events. The expo brought together thousands of industry leaders, showcasing the latest advancements in medical technology and pharmaceutical innovation. For Viva, it was an incredible opportunity to connect, collaborate, and share our vision for the future of healthcare.
Highlights from the Expo
- Showcasing InnovationViva Pharmaceutical unveiled its latest breakthroughs, including two exciting new products: Insozia and Eyestonia.
- Insozia: A cutting-edge solution designed to improve sleep cycles, helping individuals achieve restful and rejuvenating sleep.
- Eyestonia: A breakthrough product focused on eye health, supporting vision and overall ocular wellness.
- Building Global Partnerships
The expo was a perfect platform to strengthen existing relationships and forge new ones. We connected with healthcare providers, distributors, and research institutions to explore collaborations that will help us expand our global reach and bring innovative solutions like Insozia and Eyestonia to more patients worldwide.
- Sustainability in Healthcare
Sustainability was a key theme at the event, aligning with Viva’s dedication to eco-friendly practices. We participated in discussions on sustainable manufacturing and reducing the pharmaceutical industry’s environmental impact, reinforcing our commitment to a healthier planet.
Looking Ahead
Arab Health 2025 was a powerful reminder of the potential for innovation and collaboration in healthcare. Viva Pharmaceutical is more inspired than ever to push boundaries and deliver life-changing solutions like Insozia and Eyestonia. We’re excited to integrate the insights gained at the expo into our work, ensuring we continue to lead in quality, sustainability, and patient care.
Thank you to everyone who visited our booth and shared their ideas. Together, we can build a healthier future for all.
[Richmond, BC] – [Dec 17, 2024] –With the lead of Mr. Jason Ko, Viva proudly announce a generous $1 million donation to the VGH & UBC Hospital Foundation in a ceremony held Dec 9, 2024, . This significant gift will be instrumental in establishing a state-of-the-art spinal endoscopy program at Vancouver General Hospital (VGH).
Spinal endoscopy is a minimally invasive surgical technique that offers patients a less painful and faster recovery compared to traditional open-back surgeries. This innovative program will provide access to this advanced treatment for patients suffering from various spinal conditions, including herniated discs, spinal stenosis, and degenerative disc disease.
The establishment of this spinal endoscopy program at VGH marks a significant advancement in spinal care in British Columbia. By providing access to less invasive and more effective treatments, this program will improve patient outcomes and contribute to a faster recovery for individuals suffering from spinal conditions.
Read more story from VHG website :
https://vghfoundation.ca/2024/12/16/this-is-a-game-changer-1-million-gift-bringing-groundbreaking-spine-technology-to-vgh/
Richmond, BC – Viva Pharmaceutical announced that it has successfully completed its inspection by the U.S. Food and Drug Administration (USFDA), which took place from October 21 to October 25, 2024. This inspection is a critical component of the regulatory process, ensuring that pharmaceutical manufacturers adhere to stringent safety and quality standards.
During the five-day inspection, USFDA official evaluated Viva’s manufacturing processes, quality control measures, and compliance with Current Good Manufacturing Practices (cGMP). The company reported that the inspection went smoothly, reflecting its commitment to maintaining high standards in drug production.
Viva Pharmaceutical’s CEO expressed pride in the team’s dedication and hard work, stating, “This successful inspection underscores our commitment to delivering safe and effective products to our customers. We are dedicated to continuous improvement and compliance with all regulatory requirements.”
The completion of this inspection positions Viva Pharmaceutical favorably as it continues to expand its product offerings in the competitive market. The company looks forward to leveraging this positive outcome to enhance its reputation and foster trust among healthcare providers and patients alike.
Richmond, BC—[Nov 15, 2024]—Viva Pharmaceutical is delighted to announce a generous donation of $1 million to the VGH & UBC Hospital Foundation. This substantial contribution is aimed at enhancing advanced spine surgery at Vancouver General Hospital, directly impacting patient care through the acquisition of state-of-the-art endoscopic equipment and specialized training for spine surgeons.
Allocation of Funds:
- Acquisition of Advanced Endoscopic Equipment: The donation will enable the purchase of eight sets of advanced endoscopic equipment, each equipped with bipolar cautery tools. This investment is expected to significantly enhance surgical precision and reduce invasiveness.
- Training and Education for Surgeons: Spine surgeons at Vancouver General Hospital will receive comprehensive training and education on the proper use and techniques of the new equipment, ensuring the highest standards of care.
- Service and Maintenance Plan: To guarantee optimal performance, the equipment will be covered by a comprehensive service and maintenance plan provided by the vendor.
Commitment to Healthcare Excellence:
This donation highlights Viva Pharmaceutical’s steadfast commitment to advancing healthcare and improving the lives of patients in British Columbia. Through this support, Vancouver General Hospital will be better equipped to deliver cutting-edge spine surgery, ultimately enhancing patient outcomes.
Get ready, Dubai! Viva Nutraceuticals is thrilled to announce that we’ll be part of Arab Health 2025, the largest and most exciting healthcare exhibition in the Middle East. Mark your calendars for January 27-30, 2025, and make your way to the Dubai World Trade Centre for an unforgettable event!
This year, Viva Nutraceuticals is bringing something special to the table. As a global leader in health and wellness, we’re redefining the nutraceutical industry with innovative, science-backed solutions that enhance lives. Arab Health is the perfect stage to showcase our latest breakthroughs and connect with trailblazers in the healthcare world.
✨ What to Expect at Booth P.B38
• Exclusive Product Launches: Be the first to experience our newest nutraceutical innovations designed to elevate health and vitality.
• Meet the Experts: Chat with our passionate team of professionals who are ready to discuss how we can collaborate to revolutionize the industry together.
Arab Health 2025 isn’t just an event—it’s an opportunity to shape the future of healthcare. Don’t miss your chance to visit us at Booth P.B38, where excitement meets expertise, and innovation knows no limits. Whether you’re an industry leader, a healthcare innovator, or someone passionate about wellness, Viva Nutraceuticals can’t wait to connect with you.
